Work

Antimetastatic activity of ganetespib: Preclinical studies and assessment of progressions due to new lesions in the GALAXY-1 NSCLC trial.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e19097

Authors: David A Proia, Masazumi Nagai, John-Paul Jimenez, Chaohua Zhang, Jim Sang, Wei Guo, Kristin Beebe, Min-Jung Lee, Manuel Sequeira, Donald Smith, Jaime Acquaviva, Suqin He, Jane B. Trepel, Len Neckers, Safi R. Bahcall, Vojislav M. Vukovic

Institutions: Synta Pharmaceuticals (United States), National Institutes of Health, National Cancer Institute

Language: English

Topic: Heat shock proteins research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011672440

Cites:

Cited by:

Related to: 10